RxDoctor Payments Data

Cathy Hartle

Family · Columbia, MONPI 1669598710

Payments from drug & device makers

$413in general payments, 2019–2025

Across 25 payments — averaging $16.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$86
  • AbbVie$84
  • AstraZeneca$78
  • Sunovion Pharmaceuticals Inc.$43
  • E.r. Squibb & Sons, L.L.C.$42
  • Pfizer$30
  • plus $51 from 3 others

What the payments were for

  • Food & beverage$413100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$413 in reported general payments places this provider in the 50th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$7,628
Medicare patients
54
Services billed
84

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide24$34,126
EliquisApixaban34$21,464
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$13,806
SynthroidLevothyroxine Sodium37$2,812
Potassium Chloride31$2,497
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$2,179
Gabapentin79$1,775
Dexlansoprazole DrDexlansoprazole11$1,762
Tamsulosin Hcl50$1,398
Levothyroxine Sodium121$1,379
Albuterol Sulfate HfaAlbuterol Sulfate48$1,325
Omeprazole71$1,187
Atorvastatin Calcium103$917
Nebivolol Hcl17$838
Lisinopril87$668

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$86$34,12624 claims
PfizerEliquis$30$21,46434 claims
AbbVieSynthroid$84$2,81237 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,812 family providers in Missouri.

Other family in Columbia

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →